Welcome to ProbeChem!Global Supplier of Chemical Probes, Inhibitors & Agonists.

You are here:Home-Chemical Inhibitors & Agonists-Tyrosine Kinase-BMX Kinase-IHMT-15137
IHMT-15137

Chemical Structure : IHMT-15137

CAS No.:

IHMT-15137 (IHMT15137)

Catalog No.: PC-26499Not For Human Use, Lab Use Only.

IHMT-15137 is a potent and selective, irreversible BMX inhibitor with IC50 of 26.97 nM, overcomes chemoresistance in SCLC.

Packing Price Stock Quantity
50 mg Get quote
100 mg Get quote
250 mg Get quote

Bulk size, bulk discount!

E-mail: sales@probechem.com

Tech Support: tech@probechem.com

Purity & Documentation Purity: >98% (HPLC)

Biological Activity

IHMT-15137 is a potent and selective, irreversible BMX inhibitor with IC50 of 26.97 nM, overcomes chemoresistance in SCLC.
IHMT-15137 displays potent anti-proliferative activity with GI50 of 0.83 nM in TEL-BMX-BaF3 cells.
IHMT-15137 significantly stabilized the BMX protein in cellular thermal shift assay (CETSA) assays, protected BMX from proteolysis in a dose-dependent manner in cell lysates from H446DDPR and H69AR cells.
IHMT-15137 (0-10 uM) effectively inhibited the phosphorylation of BMX (Tyr566) in a dose-dependent manner in TEL-BMX-BaF3 cells, also induced dose-dependent decrease in the phosphorylation levels of BMX (Tyr566), ERK1/2 (Thr202/Tyr204), and STAT3 (Tyr705) in chemoresistant SCLC cells, H446DDPR and H69AR.
IHMT-15137 effectively overcomes chemoresistance in SCLC through multiple mechanisms, including suppressing cell proliferation, inducing apoptosis, inhibiting metastasis, and impairing DNA repair, which are mediated through disruption of the BMX-ERK1/2-Cyclin D1/CDK4/6-E2F1 signaling axis.
IHMT-15137 overcomes cisplatin resistance in SCLC PDC models.

Physicochemical Properties

M.Wt 446.43
Formula C21H21F3N6O2
Appearance Solid
CAS No.
Storage
Solide Powder
-20°C 12 Months; 4°C 6 Months
In Solvent
-80°C 6 Months; -20°C 6 Months
Shipping
Solubility

10 mM in DMSO

Chemical Name/SMILES

2-(1-acryloylpiperidin-3-yl)-N-(3-(5-(trifluoromethyl)-1H-benzo[d]imidazol-2-yl)-1H-pyrazol-4-yl)acetamide

References

1. Wu T, et al. Signal Transduct Target Ther. 2026 Apr 8;11(1):125.

Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright

Contact Us sales@probechem.com

Bulk Inquiry

* Indicates a Required FieldYour information is safe with us.

  • *Product name:
  • *Applicant name:
  • *Email address:
  • *Organization name:
  • *Requested quantity:
  • *Country:
  • *Additional Information:

Get Quote

* Indicates a Required FieldYour information is safe with us.

  • *Product name:
  • *Applicant name:
  • *Email address:
  • *Organization name:
  • *Requested quantity:
  • *Country:
  • Additional Information: